SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001571049-16-020143
Filing Date
2016-11-23
Accepted
2016-11-23 16:47:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 FINAL PROSPECTUS t1602924_424b2.htm 424B2 612505
2 GRAPHIC t1602924_logo.jpg GRAPHIC 27593
3 GRAPHIC t1602924_p19.jpg GRAPHIC 42866
  Complete submission text file 0001571049-16-020143.txt   710878
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-214230 | Film No.: 162017117
SIC: 2834 Pharmaceutical Preparations